-
Emerging Targets in Non-Small Cell Lung Cancer
06 Sep 2025 06:12 GMT
… cell lung cancer (NSCLC) represents approximately 85% of all lung cancer … and active metabolite of irinotecan. After binding to TROP2 … in non-small cell lung cancer: molecular mechanisms and … advanced non-small cell lung cancer. Lung Cancer. 2023;182:107291. …
-
New Trials Advance Treatments for Lymphoma, Lung Cancer and Sarcomas
25 Jul 2025 21:47 GMT
… sarcomas and ALK-positive lung cancer. Several clinical trials … or in combination with irinotecan, irinotecan plus temozolomide, or … Evaluating Neladalkib for Lung Cancer Subset
The first … -positive non-small cell lung cancer, versus Alecensa (alectinib), …
-
Predictive Value of Tumor ERCC1 Expression for Treatment Outcomes After Adjuvant Chemotherapy in Patients with Completely Resected Non-Small Cell Lung Cancer
19 Jul 2025 11:24 GMT
… Keywords: non-small cell lung cancer, postoperative adjuvant chemotherapy, … resected non-small cell lung cancer. Lung Cancer. 2008;62(1):105 … cisplatin-based concurrent chemoradiotherapy. Lung Cancer. 2010;68(2): … phase III trial of irinotecan plus S-1 versus …
-
Anlotinib/Irinotecan Shows Promise, Durable Responses in ES-SCLC
15 Aug 2025 05:19 GMT
… with extensive-stage small cell lung cancer (ES-SCLC) who … trial (NCT04757779) published in Lung Cancer.
In the 37 patients … irinotecan as second-line therapy in extensive-stage small-cell lung cancer … single-arm phase II study. Lung Cancer. 2025;205:108630. …
-
Prognostic Value of C-Reactive Protein-to-Lymphocyte Ratio in Combined Immunotherapy and Chemotherapy for Small Cell Lung Cancer
16 Jul 2025 17:40 GMT
… 20% of all lung cancers.2 Recent advancements … nab-paclitaxel, and irinotecan. Treatment continued with maintenance … with advanced small cell lung cancer. Lung Cancer. 2017;8:249– … and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. …
-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. … non-small cell lung cancer patients. Lung Cancer. 2011;72 … ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer …
-
Feasibility and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in Patients with Previously Immunotherapy-Treated Extensive-Stage Small Cell Lung Cancer: A Retrospective Exploratory Study
09 Jun 2025 10:12 GMT
… small cell lung cancer: a retrospective cohort study. Transl Lung Cancer Res. … the study of lung cancer--what limits limited disease? Lung Cancer. 2002;37 … irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer. Lung Cancer …
-
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
02 Jun 2025 16:00 GMT
… and Non-Small Cell Lung Cancer
Two presentations at the … results at ASCO. In lung cancer, patient recruitment is progressing … metastatic non-small cell lung cancer and secondary resistance to … folinic acid, fluorouracil and irinotecan
2 FOLFIRINOX: A combination …
-
Adebrelimab in Small Cell Lung Cancer: From Current Advances to Emerging Combination Strategy and Challenge
31 May 2025 15:01 GMT
… adebrelimab combined with irinotecan liposomes in patients … sites and survival in lung cancer. Lung Cancer. 2014;86(1 … cell lung cancer: a multicenter retrospective analysis. Transl Lung Cancer Res … lung cancer progressing after 2 lines of therapy. Lung Cancer. …
-
ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement
23 May 2025 00:55 GMT
… position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca … line extensive-stage small cell lung cancer (ES-SCLC) significantly … or in combination with irinotecan against the physician’s … choice of topotecan or irinotecan.
Jazz in-licensed U …
About
© 1995-2025